Activated polymorphonuclear derived extracellular vesicles are potential biomarkers of periprosthetic joint infection

Imre Sallai1, Nikolett Marton2, Attila Szatmári1

  • 1Department of Orthopaedics, Semmelweis University, Budapest, Hungary.

Plos One
|May 9, 2022
PubMed
Abstract

Insights

Activated polymorphonuclear (PMN)-derived extracellular vesicles (EVs) are more numerous and have distinct characteristics in periprosthetic joint infection (PJI) patients. These EVs may serve as potential biomarkers for diagnosing PJI.

Area of Science:

  • Biomedical research
  • Orthopedics
  • Immunology

Background:

  • Extracellular vesicles (EVs) play vital roles in biological processes, including joint diseases.
  • Their specific function in periprosthetic joint infection (PJI) remains underexplored.
  • This study investigates activated polymorphonuclear (PMN)-derived synovial EVs in PJI patients.

Purpose of the Study:

  • To compare the number and size of EVs in PJI versus aseptic loosening.
  • To determine morphological differences in EVs between PJI and aseptic loosening.
  • To identify activated PMN-derived EVs in septic samples and analyze protein composition differences.

Main Methods:

  • Analysis of periprosthetic joint fluid from 34 patients (17 PJI, 17 aseptic loosening).
  • EV separation followed by nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and flow cytometry (Annexin V, CD177 labelling).
  • Protein content analysis using mass spectrometry (MS).

Main Results:

  • Significantly higher EV concentration and different size patterns in PJI samples compared to aseptic loosening.
  • TEM confirmed vesicular nature; flow cytometry showed increased activated PMN-derived EVs in PJI.
  • MS identified significant differences in protein abundance, including lactotransferrin and myeloperoxidase.

Conclusions:

  • Activated PMN-derived EVs are increased in PJI synovial fluid, exhibiting unique size and protein profiles.
  • These activated EVs show potential as diagnostic biomarkers for periprosthetic joint infection.
  • Further research can validate these EVs for clinical PJI detection.